Feb 29, 2016
In this episode, depression, inflammation, sleep and mindfulness
all come under the spotlight.
The sleep research:
Westermann J, Lange T, Textor J and Born J (2015) System
consolidation during sleep - a common principle underlying
psychological and immunological memory formation Trends in
Neurosciences 38(10): 585-597
Cordi MJ, Schlarb AA and Rasch B (2014) Deepening sleep by hypnotic
suggestion Sleep 37(6): 1143-1152
Professor Millers depression and cytokine
research:
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C.,
Schettler, P., Drake, D. F., Haroon E and Miller A H (2013) A
randomized controlled trial of the tumor necrosis factor antagonist
infliximab for treatment-resistant depression: the role of baseline
inflammatory biomarkers JAMA Psychiatry 70(1): 31-41
Two reviews of the role of cytokines in depression can be
read here:
Köhler O, Benros ME, Nordentoft M, Farkouh ME, Iyengar RL, Mors O
and Krogh J (2014) Effect of anti-inflammatory treatment on
depression, depressive symptoms, and adverse effects: a systematic
review and meta-analysis of randomized clinical trials JAMA
Psychiatry 71(12): 1381-1391
Mills NT, Scott JG, Wray NR, Cohen‐Woods S and Baune BT (2013)
Research review: the role of cytokines in depression in
adolescents: a systematic review Journal of Child Psychology and
Psychiatry 54(8) 816-835
The MBCT and depression research:
Kuyken W, Hayes R, Barrett B, Byng R, Dalgleish T, Kessler D, Lewis
G, Watkins E, Brejcha C, Cardy J, Causley A, Cowderoy S, Evans A,
Gradinger F, Kaur S, Lanham P, Morant, N, Richard J, Shah P, Sutton
H, Vicary R, Weaver A, Wilks J, Williams M, Taylor RS and Byford S
(2015) Effectiveness and cost-effectiveness of mindfulness-based
cognitive therapy compared with maintenance antidepressant
treatment in the prevention of depressive relapse or recurrence
(PREVENT): a randomised controlled trial The Lancet 386(9988):
63-73